Literature DB >> 27492097

Femtosecond laser penetrating corneal relaxing incisions combined with cataract surgery.

Li Wang1, Suhua Zhang2, Zhe Zhang1, Douglas D Koch1, Yading Jia1, Weifang Cao1, Xiaoyan Li1.   

Abstract

PURPOSE: To evaluate the effectiveness of femtosecond laser penetrating corneal relaxing incisions (CRIs) in reducing corneal astigmatism during cataract surgery.
SETTING: Shanxi Eye Hospital, Taiyuan, Shanxi Province, China.
DESIGN: Prospective case series.
METHODS: Using the Lensx laser, CRIs were placed at a diameter of 8.0 mm with a depth of 90%. Corneal astigmatism was measured before surgery and 1 and 3 months after surgery. Vector analyses were performed. To obtain the net corneal changes, the with-the-wound (WTR) and against-the-wound (ATR) changes were calculated along the meridian of the CRI. Multiple regression analysis with generalized estimating equations was used to evaluate the factors contributing to the effectiveness of CRIs.
RESULTS: The study comprised 51 eyes. One and 3 months postoperatively, respectively, the mean keratometric astigmatism was reduced significantly by 0.65 diopter (D) and 0.67 D (both P < .05); compared with preoperative corneal astigmatism, the percentage of eyes within ±0.50 D of refractive astigmatism significantly increased by 42.6% and 46.7% (both P < .05) and the mean refractive astigmatism was significantly decreased at 1 month (0.27 @ 93 versus 0.17 × 17) (P < .05) but not at 3 months (0.09 @ 138 versus 0.07 × 172) (P > .05). The mean WTW and ATW changes were -1.05 D and -1.00 D, respectively, and 14.9% and 6.7% of eyes, respectively, were overcorrected. Age, CRI length, and CRI location were factors contributing to net corneal changes. A nomogram is proposed.
CONCLUSION: Femtosecond laser CRIs were effective in reducing corneal astigmatism during cataract surgery, and their long-term effectiveness should be evaluated. FINANCIAL DISCLOSURE: Dr. Koch is a consultant to Abbott Medical Optics, Inc., Alcon Laboratories, Inc., and Revision Optics, Inc. None of the other authors has a financial or proprietary interest in any material or method mentioned.
Copyright © 2016 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27492097     DOI: 10.1016/j.jcrs.2016.04.020

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Evaluation of Femtosecond Laser Intrastromal Incision Location Using Optical Coherence Tomography.

Authors:  Li Wang; Lai Jiang; Katie Hallahan; Zaina N Al-Mohtaseb; Douglas D Koch
Journal:  Ophthalmology       Date:  2017-04-12       Impact factor: 12.079

Review 2.  Femtosecond laser-assisted astigmatic keratotomy: a review.

Authors:  John S M Chang
Journal:  Eye Vis (Lond)       Date:  2018-03-12

3.  A Novel Sequential Docking Technique: Use of Femtosecond Arcuate Keratotomy and Femtosecond Assisted Cataract Surgery Using a Pupil Expansion Ring on a Patient with Intraoperative Floppy Iris Syndrome.

Authors:  Hung-Yuan Lin; Ting-Yu Lin; Ya-Jung Chuang; Li-Ju Lai; Pi-Jung Lin
Journal:  Int Med Case Rep J       Date:  2020-04-23

4.  Comparison of penetrating femtosecond laser-assisted astigmatic keratotomy and toric intraocular lens implantation for correction of astigmatism in cataract surgery.

Authors:  Hoon Noh; Young-Sik Yoo; Kyoung Yoon Shin; Dong Hui Lim; Tae-Young Chung
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

5.  Prediction of corneal astigmatism based on corneal tomography after femtosecond laser arcuate keratotomy using a pix2pix conditional generative adversarial network.

Authors:  Zhe Zhang; Nan Cheng; Yunfang Liu; Junyang Song; Xinhua Liu; Suhua Zhang; Guanghua Zhang
Journal:  Front Public Health       Date:  2022-09-16

6.  Efficacy of 0.015% intracameral epinephrine for significant miosis induced by photodisruption during femtosecond laser-assisted cataract surgery.

Authors:  Jong Hwa Jun; Seung Pil Bang; Young-Sik Yoo; Choun-Ki Joo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.